Study Stopped
Funding was not received.
A Breathing-Based Meditation Intervention for Patients With Treatment Resistant Late Life Depression
1 other identifier
interventional
N/A
0 countries
N/A
Brief Summary
Late-life depression affects 2-8% of seniors and causes high rates of caregiver distress and risk of suicide. To exacerbate the problem, antidepressants, the cornerstone of therapy, are resistant in 55-80% of this population. Hence, this group of patients is labeled as having treatment-resistant late-life depression (TR-LLD). Non-pharmacological interventions like meditation could offer significant benefits as augmentation strategies to improve response rate of antidepressants in TR-LLD. One such breath-based meditation intervention called Sudarshan Kriya Yoga is of interest based on highly significant preliminary data in adult patients with treatment-resistant depression, its scalability and relatively low cost to learn this lifelong skill. Thirty patients diagnosed with TR-LLD will learn this intervention over 5 consecutive days by a certified para-professional trainer. This will be followed by 3 weekly 90 min follow-up sessions and then bimonthly sessions for 8 more weeks. SKY consists of a series of breathing techniques, including Sudarshan Kriya (SK), a sequential rhythm-specific breathing exercise. Participants will be asked to practice this technique for 25-30 minutes daily over the next 11 weeks. The investigators will collect clinical as well as feasibility outcome measures. The investigators will also explore if it is feasible to assess the antioxidant Glutathione (GSH) in the brain using a sophisticated magnetic resonance spectroscopy. The investigators suspect that GSH levels are reduced in TR-LLD and they will improve with SKY.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jan 2020
Typical duration for phase_1
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 27, 2017
CompletedFirst Posted
Study publicly available on registry
December 11, 2017
CompletedStudy Start
First participant enrolled
January 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2022
CompletedJune 25, 2018
June 1, 2018
3 years
November 27, 2017
June 20, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Severity of TR-LLD as measured by the Hamilton Depression Scale (HAM-D17).
The primary outcome measure will be the Hamilton Depression Rating Scale (HAM-D 17) score. The HAM-D17 rates symptoms commonly associated with Major Depressive Disorder (MDD). A total score is calculated based on the first 17 questions of the HAM-D with a score range of 0 to 53. A higher score indicates more severe depression, and a lower score indicates fewer and/or less severe symptoms of depression.
12 weeks
Secondary Outcomes (4)
Glutathione levels measured by a 7-Tesla Magnetic Resonance Imaging (7T-MRI) in TR-LLD.
12 weeks
Caregiver burden in caregivers of TR-LLD as measured by the Zaritz Caregiver Burden scale.
12 weeks
Quality of Life of TR-LLD participants using the European Quality of Life (EQ-5D-5L) scale.
12 weeks
Anxiety severity of TR-LLD participants measured by the Geriatric Anxiety Inventory (GAI).
12 weeks.
Study Arms (2)
Sudarshan Kriya Yoga
ACTIVE COMPARATORThirty participants with treatment-resistant late life depression (TR-LLD) will attend 5 instructional days of Sudarshan Kriya Yoga (SKY), followed by 3 weekly follow-ups, and 8 weeks of bimonthly follow-ups. Participants will also practice SKY for 25 minutes per day at home. These participants will attend 4 mental health assessments at weeks 0, 4, 8, and 12. Thirteen of the recruited TR-LLD will attend an MRI at baseline and post-intervention.
Control
NO INTERVENTIONThe seven recruited age-matched controls will complete a screening appointment and an MRI only for comparison. Demographic information will also be collected from the control participants. These individuals will not undergo the study intervention.
Interventions
Sudarshan Kriya Yoga (SKY): A 12-week training course conducted by certified instructors from the Art of Living Foundation. SKY training will take place in group-format (group sizes of 8-15 participants) in an appropriately sized and accessible community hall in London, Ontario.SKY training involves attending a week-long (5 days) course that teaches the basic principles of SKY over 2.5-3 hour daily sessions. This will be followed by once weekly follow up sessions (90 min/wk) for 3 weeks and then bimonthly sessions (every 2 weeks) for the next 8 weeks. In addition, participants will be asked to practice SKY at home daily (25 min/day) throughout the duration of the study period and log practice frequency and any other noteworthy observations in a log sheet that will be provided to them . Nutritional snacks will be provided during the 5 day SKY training course.
Eligibility Criteria
You may qualify if:
- years of age
- major depressive disorder, as per the results of an interview by a trained rater using the Structured Clinical Interview for DSM-5 and subsequently confirmed by the psychiatrist
- Mild to moderate depression as confirmed by a score on the HAM-D 17 between 8 and 23
- Have failed at least two trials of antidepressants, given at adequate doses for adequate duration during the current episode
- Able to follow verbal instructions and sit without physical discomfort for 45 minutes
- Willing and able to attend at least 75% of all Sudarshan Kriya Yoga (SKY) sessions
- Willing to dedicate 25-30 minutes/day to SKY practice at home
- Low risk of suicide based on a clinical initial interview and during follow-up interviews at weeks 4, 8 and 12.
You may not qualify if:
- Uncontrolled hypertension, seizure disorder, psychosis, substance abuse, or dementia
- Currently participating in other similar studies or currently practicing any type of formal meditation, mindfulness or breathing techniques
- A major surgery within 6 weeks prior to commencement of or scheduled during, the study intervention
- A traumatic brain injury
- Any contraindications to MRI will also be excluded
- Healthy control participants must have no significant mental health issues, or contraindications to MRI.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MBBS, MD, MRCPsych, PG Cert Medical Education Associate Professor of Psychiatry and Medicine, Western University Consultant Geriatric Psychiatrist, London Health Sciences Centre
Study Record Dates
First Submitted
November 27, 2017
First Posted
December 11, 2017
Study Start
January 1, 2020
Primary Completion
December 31, 2022
Study Completion
December 31, 2022
Last Updated
June 25, 2018
Record last verified: 2018-06
Data Sharing
- IPD Sharing
- Will not share